Florida is one of the fastest growing bioscience regions in the world. With a strong base of biotechnology, medical devices and pharmaceutical companies, world-class research universities and some of the leading non-profit research institutes in the world, Florida has built a resource base to be a top bioscience destination.
BioFlorida members can access other members as well as a library of industry data, links, and other resources via the members-only pages of this site.
More Than 400 Innovative Medicines in Development For Top Chronic Diseases Affecting Older Americans; Two Reports Show Progress in Treatment Options for Chronic Disease
Medicines in Development - Older Americans Overview
Medicines in Development - Older Americans 2013 Report
Backgrounder - Selected Medicines in Development for Older Americans
Backgrounder - Clinical Trials: Older Americans and Chronic Diseases
Click here for the second edition of Florida's BioPulse
Florida’s bioscience industry continued to show steady growth during 2012, outpacing the national average. Florida’s biotechnology sector grew by 60 percent over the past five years compared to a nationwide increase of less than 5 percent over the same period according to the report released today by BioFlorida. Furthermore, Florida has experienced a 13.5 percent increase in the number of biotech companies since the first quarter of 2012. The second edition of Florida’s BioPulse, titled "A Snapshot of Bio Business and Talent,” provides top-level insight on the growth of the industry by the University of Florida’s Sid Martin Biotechnology Incubator. The snapshot is based on its Florida BioDatabase plus a selection of talent development programs at top academic and learning institutions in Florida.
"The new data is evidence of a strong, innovative and sustainable bioscience business climate here in Florida,” says David L. Day, Assistant Vice President of the University of Florida Office of Technology Licensing and the Sid Martin Biotechnology Incubator. "Not only is Florida experiencing growth in the number of biotechnology businesses, we are also seeing a continued increase in venture capital investments—demonstration of investor confidence in our biotechnology start-ups and breakthrough research.”
Venture funding in 2012 was the best year for Florida since 2007, the report highlights. New data shows Florida experienced a 27 percent growth in life science deals in 2012 (from 15 to 19) as venture dollars rose to $103.5 million, representing a 19 percent increase compared to 2011. Nationally, the United States experienced a 13 percent decline in life science funding, according to newly released data from the National Venture Capital Association.
In addition, the BioPulse provides an overview of talent development programs in place to support the growing industry by institutions including Moffitt Cancer Center, Vaccine and Gene Therapy Institute of Florida and Max Planck Florida Institute for Neuroscience.
Click here for the first edition of Florida's BioPulse
While other states are seeing a decline in biotechnology investment and entrepreneurship, the biotechnology industry in Florida continues to grow, with venture capital investments surging by 200 percent, according to a report released by BioFlorida. Florida’s BioPulse – A Snapshot of the Bioscience Industry, provides top-level insight on the growth of the industry by the University of Florida’s Sid Martin Biotechnology Incubator based on its Florida BioDatabase.
Florida’s BioPulse provides a snapshot of what the bioscience industry has been doing over the past eight years. It credits the growth of the biotechnology industry in Florida as having been sparked by Florida’s commitment – beginning under then Governor Jeb Bush – to establish a life sciences industry in the state by attracting major research institutes such as Scripps Research Institute. According to the report, the industry has grown by 42 percent over the past five years, with nearly 200 biotechnology companies calling Florida home. In addition, biomedical venture capital investments increased during 2011 in Florida – 200 percent more than in 2010, with nearly $87 million. While this number is less in absolute dollars when compared to the leading bioscience states, the percentage growth of venture capital investments is much larger.
BioFlorida released the first edition of the bi-annual report, Florida’s BioPulse, during the BIO International Convention and on the heels of Battelle’s – the world’s largest independent research and development organization – Annual Report. The Battelle report, which can be found here: http://www.bio.org/battelle2012
provides a more detailed and comprehensive look at the entire bioscience industry across the United States. The 2012 report supports the information published in Florida’s BioPulse, finding that from 2001 to 2010 industry business establishments grew by close to 33 percent and job growth increased almost 19 percent in Florida – while the nation experienced a business establishment increase of less than 13 percent and industry job growth of only 6.4 percent.
The Battelle report also indicates the investment in research in the state is having a positive impact on Florida’s private sector, as the drugs and pharmaceuticals sector shows the largest growth among the top 10 employment states from 2001 to 2010, with business establishments increasing by 74 percent during the time period. The overall bioscience sector grew over 30% in companies during that same period while Florida's overall private sector employment shrank by almost 2%.
Rankings among Top 10 bioscience employment states:
• #2 for number of bioscience companies (5,102)
• #6 for bioscience employment (78,062)
• #1 in bioscience distribution companies (2,982)
• #2 in medical device companies (498)
• #4 in drugs & pharmaceuticals companies (155)
Growth rate among Top 10 bioscience employment states:
• 2001-2010: #1 in growth rate for drugs & pharmaceuticals companies (+74%)
• 2001-2010: #1 in growth rate for drugs & pharmaceuticals employment (+22%)
• 2007-2010 (recession): #1 in growth rate for drugs & pharmaceuticals companies (+48%)
• 2001-2010: #1 in growth rate for medical device companies (+51%)
• 2007-2010 (recession): #1 in growth rate for medical device companies (+32%)